DRUIE E. CAVENDER

机构：Johnson & Johnson (United States), University of Texas Health Science Center at Dallas, The University of Texas Southwestern Medical Center, The University of Texas Health Science Center at Houston

发表论文 84 篇 · 总被引 4183 次 · h-index 33

代表论文

• Imidazopyrimidines, potent inhibitors of p38 MAP kinase (2003 · Bioorganic & Medicinal Chemistry Letters · 被引 255)
• Interleukin (IL)-1 Receptor–associated Kinase (IRAK) Requirement for Optimal Induction of Multiple IL-1 Signaling Pathways and IL-6 Production (1998 · The Journal of Experimental Medicine · 被引 194)
• RWJ 67657, a Potent, Orally Active Inhibitor of p38 Mitogen-Activated Protein Kinase (1999 · Journal of Pharmacology and Experimental Therapeutics · 被引 158)
• Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. (1989 · PubMed · 被引 104)
• Anti-Inflammatory Doses of Ibuprofen: Effect on Neutrophils and Exercise-Induced Muscle Injury (1999 · International Journal of Sports Medicine · 被引 81)
• 6-Amino-2-(4-fluorophenyl)-4-methoxy-3- (4-pyridyl)-1H-pyrrolo[2,3-b]pyridine (RWJ 68354): A Potent and Selective p38 Kinase Inhibitor (1998 · Journal of Medicinal Chemistry · 被引 77)